News & Updates

In adolescents living with HIV, a 5-days-on and 2-days-off dosing of antiretroviral therapy (ART) with tenofovir disoproxil fumarate, lamivudine, and dolutegravir fails to match the efficacy of continuous dosing for maintaining viral suppression, as shown in the BREATHER Plus trial conducted in Africa.

Offering low-sweet snacks and caregiver education can help reduce daily added sugar and sugar-sweetened beverage (SSB) intakes among children and their caregivers, according to a study.

Treatment with dupilumab for up to 100 weeks reduces the frequency and severity of symptoms in children with eosinophilic esophagitis (EoE), as measured by the validated Pediatric Eosinophilic Esophagitis Symptom Score version 2.0 (PEESSv2.0), according to results from the open-label extension of the phase III EoE KIDS study.

An online, team-based connected health (TCH) model of care does not appear to be any different than in-person care in terms of improving outcomes in patients with atopic dermatitis (AD), according to a study.

Paediatric patients with moderately to severely active ulcerative colitis (UC) show a favourable response to ustekinumab administered once every 4 weeks (Q4W), according to a study. This results in greater clinical response and remission associated with higher serum drug levels.

In children and adults with developmental and epileptic encephalopathies (DEEs), treatment with fenfluramine appears to be effective with predictable tolerability, as shown in a real-world study.

Better maternal cardiovascular health during pregnancy is associated with a lower risk of developmental delay in offspring, whereas poor maternal cardiovascular health during pregnancy contributes to a risk increase, according to a study.

New drug applications approved by US FDA as of 16-30 June 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

In vitro exposure to acid-suppressive medications does not appear to be associated with an increased risk of inflammatory bowel disease (IBD) development in offspring, as shown in a nationwide cohort study.